Evidence map›Paper›PMID 27777235›Full record

Trial reportCancer prevention research (Philadelphia, Pa.)2017

Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.

Peter Lance, David S Alberts, Patricia A Thompson, Liane Fales, Fang Wang, Jerilyn San Jose, Elizabeth T Jacobs, Phyllis J Goodman, Amy K Darke, Monica Yee and 3 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Cancer prevention research (Philadelphia, Pa.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Preventing Colitis-Associated Colon Cancer With Antioxidants: A Systematic Review.Cellular and molecular gastroenterology and hepatology · 2021
    Pooled it
  2. Selenium for preventing cancer.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Environmental Selenium and Human Health: an Update.Current environmental health reports · 2018
    Review
  14. Selenoproteins in colon cancer.Free radical biology & medicine · 2018
    Review
  15. Review
  16. Observational
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Peter LanceUniversity of Arizona Cancer Center, Tucson, Arizona. plance@uacc.arizona.edu.
David S AlbertsUniversity of Arizona Cancer Center, Tucson, Arizona.
Patricia A ThompsonUniversity of Arizona Cancer Center, Tucson, Arizona.
Liane FalesUniversity of Arizona Cancer Center, Tucson, Arizona.
Fang WangUniversity of Arizona Cancer Center, Tucson, Arizona.
Jerilyn San JoseUniversity of Arizona Cancer Center, Tucson, Arizona.
Elizabeth T JacobsUniversity of Arizona Cancer Center, Tucson, Arizona.
Phyllis J GoodmanSWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Amy K DarkeSWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Monica YeeSWOG Statistical Center, Cancer Research and Biostatistics, Seattle, Washington.
Lori MinasianDivision of Cancer Prevention, NCI, Bethesda, Maryland.
Ian M ThompsonUniversity of Texas Health Sciences Center, San Antonio, Texas.
Denise J RoeUniversity of Arizona Cancer Center, Tucson, Arizona.
University of Arizona · USFred Hutch Cancer Center · USCancer Research And Biostatistics · USCenter for Cancer Research · USThe University of Texas Health Science Center at San Antonio · US

Funding

SWOG Foreign AccrualsU10CA037429 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BLANKE, CHARLES D., MEYSKENS, FRANK L. · 1985 to 2014
$205.2M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
WHEAT BRAN FIBER SUPPLEMENTS ON THE RECURRENCE OF COLONIC ADENOMASP01CA041108 · NCI · UNIVERSITY OF ARIZONA · PI HAMILTON, STANLEY R. · 1986 to 2009
$38.8M
Selenium Colorectal Cancer Chemoprevention TrialsR01CA151708 · NCI · UNIVERSITY OF ARIZONA · PI JACOBS, ELIZABETH T · 2011 to 2021
$6.8M
PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research UM1CA182883 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TANGEN, CATHERINE M., THOMPSON, IAN M. · 2013 to 2017
$5.2M
Colorectal Neoplasia in SELECT ParticipantsR01CA124862 · NCI · UNIVERSITY OF ARIZONA · PI LANCE, M. PETER · 2007 to 2011
$2.7M
NCI NIH HHS P01 CA041108NCI NIH HHS R01 CA124862NCI NIH HHS R01 CA151708NCI NIH HHS U10 CA037429NCI NIH HHS UG1 CA189974NCI NIH HHS UM1 CA182883
6 · The paper itself

Abstract

Selenium and vitamin E micronutrients have been advocated for the prevention of colorectal cancer. Colorectal adenoma occurrence was used as a surrogate for colorectal cancer in an ancillary study to the Selenium and Vitamin E Cancer Prevention Trial (SELECT) for prostate cancer prevention. The primary objective was to measure the effect of selenium (as selenomethionine) on colorectal adenomas occurrence, with the effect of vitamin E (as α-tocopherol) supplementation on colorectal adenoma occurrence considered as a secondary objective. Participants who underwent lower endoscopy while in SELECT were identified from a subgroup of the 35,533 men randomized in the trial. Adenoma occurrence was ascertained from the endoscopy and pathology reports for these procedures. Relative Risk (RR) estimates and 95% confidence intervals (CI) of adenoma occurrence were generated comparing those randomized to selenium versus placebo and to vitamin E versus placebo based on the full factorial design. Evaluable endoscopy information was obtained for 6,546 participants, of whom 2,286 had 1+ adenomas. Apart from 21 flexible sigmoidoscopies, all the procedures yielding adenomas were colonoscopies. Adenomas occurred in 34.2% and 35.7%, respectively, of participants whose intervention included or did not include selenium. Compared with placebo, the RR for adenoma occurrence in participants randomized to selenium was 0.96 (95% CI, 0.90-1.02; P = 0.194). Vitamin E did not affect adenoma occurrence compared with placebo (RR = 1.03; 95% CI, 0.96-1.10; P = 0.38). Neither selenium nor vitamin E supplementation can be recommended for colorectal adenoma prevention. Cancer Prev Res; 10(1); 45-54. ©2016 AACR.

Indexed as

AdenomaAgedalpha-TocopherolAntioxidantsColorectal NeoplasmsDietary SupplementsHumansIncidenceMaleMiddle AgedProstatic NeoplasmsRisk FactorsSelenomethionineSigmoidoscopyalpha-TocopherolAntioxidantsSelenomethionine

Identifiers

PMID27777235
PMCPMC5510661
OpenAlexW2537875943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.